Mashio Nakamura Selected Research

darexaban

3/2014	Darexaban for the prevention of venous thromboembolism in Asian patients undergoing orthopedic surgery: results from 2 randomized, placebo-controlled, double-blind studies.
9/2012	Darexaban (YM150) prevents venous thromboembolism in Japanese patients undergoing major abdominal surgery: Phase III randomized, mechanical prophylaxis-controlled, open-label study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mashio Nakamura Research Topics

Disease

37	Venous Thromboembolism 03/2024 - 11/2006
26	Hemorrhage 03/2024 - 12/2002
26	Pulmonary Embolism 09/2023 - 12/2002
25	Venous Thrombosis (Deep-Vein Thrombosis) 09/2023 - 12/2002
15	Neoplasms (Cancer) 03/2024 - 04/2006
7	Heart Failure 11/2022 - 02/2010
7	Coronary Artery Disease (Coronary Atherosclerosis) 11/2022 - 07/2002
6	Hypertension (High Blood Pressure) 11/2022 - 05/2010
5	Body Weight (Weight, Body) 01/2022 - 11/2012
4	Atrial Fibrillation 01/2023 - 06/2012
4	Stroke (Strokes) 12/2019 - 04/2006
3	Thromboembolism 01/2023 - 06/2017
3	Embolism (Embolus) 12/2019 - 05/2007
3	Thrombosis (Thrombus) 01/2015 - 09/2010
3	Myocardial Ischemia (Ischemic Heart Diseases) 09/2013 - 07/2002
3	Heart Arrest (Cardiac Arrest) 01/2012 - 01/2009
2	Acute Coronary Syndrome 01/2023 - 03/2022
2	Diabetes Mellitus 01/2023 - 11/2022
2	Ischemic Stroke 01/2023 - 03/2022
2	Myocardial Infarction 01/2022 - 07/2002
2	Intellectual Disability (Idiocy) 09/2019 - 12/2018
1	Transient Ischemic Attack 03/2024
1	Cerebral Infarction 03/2024
1	Hyperuricemia 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Contusions 09/2019
1	Cardiac Tamponade 11/2018
1	Hyperemia 01/2018
1	Inflammation (Inflammations) 01/2018
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Albuminuria 10/2017
1	Edema (Dropsy) 01/2017
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2017
1	Hypokalemia 01/2017
1	Thrombocytopenia (Thrombopenia) 02/2016

Drug/Important Bio-Agent (IBA)

15	AnticoagulantsIBA 09/2023 - 06/2012
15	RivaroxabanIBA 08/2023 - 06/2017
10	edoxabanIBA 02/2020 - 06/2014
9	Warfarin (Coumadin)FDA LinkGeneric 06/2023 - 06/2012
7	Heparin (Liquaemin)FDA LinkGeneric 01/2018 - 01/2011
5	apixabanIBA 01/2024 - 01/2015
5	CreatinineIBA 01/2023 - 10/2017
4	fibrin fragment D (D-dimer)IBA 03/2024 - 06/2012
4	Fondaparinux (Arixtra)FDA Link 02/2016 - 01/2011
4	Enoxaparin (Lovenox)FDA LinkGeneric 01/2015 - 06/2014
3	Factor Xa InhibitorsIBA 01/2023 - 09/2012
3	vinyltriethoxysilane (VTES)IBA 03/2022 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2018
2	Hemoglobins (Hemoglobin)IBA 01/2018 - 04/2015
2	Angiotensin Receptor AntagonistsIBA 10/2017 - 01/2013
2	Tolvaptan FDA Link 01/2017 - 12/2012
2	darexabanIBA 03/2014 - 09/2012
2	Parathyroid Hormone (Parathormone)IBA 01/2014 - 01/2013
1	FibrinIBA 01/2023
1	HDL LipoproteinsIBA 11/2022
1	Immunologic Factors (Immunomodulators)IBA 11/2022
1	Uric Acid (Urate)IBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	N(4)-oleylcytosine arabinosideIBA 12/2019
1	Sitagliptin Phosphate (Januvia)FDA Link 01/2018
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2018
1	A-factor (Streptomyces)IBA 01/2018
1	GlucosidasesIBA 01/2018
1	voglibose (Basen)IBA 01/2018
1	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 10/2017
1	Eplerenone (Inspra)FDA LinkGeneric 10/2017
1	AlbuminsIBA 10/2017
1	Anesthetics (Anesthetic Agents)IBA 05/2017
1	Furosemide (Lasix)FDA LinkGeneric 01/2017
1	ElectrolytesIBA 01/2017
1	DiureticsIBA 01/2017
1	Sildenafil Citrate (Viagra)FDA Link 01/2017
1	PotassiumIBA 01/2017
1	ambrisentan FDA Link 01/2017
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2017
1	AntibodiesIBA 02/2016
1	Platelet Factor 4IBA 02/2016

Therapy/Procedure

17	Therapeutics 06/2023 - 06/2003
6	Vena Cava Filters (Inferior Vena Cava Filter) 09/2023 - 12/2002
3	Percutaneous Coronary Intervention 01/2022 - 09/2013
3	Arthroplasty 05/2017 - 11/2012
3	Hip Replacement Arthroplasty (Total Hip Replacement) 05/2017 - 11/2012
3	Knee Replacement Arthroplasty (Total Knee Replacement) 05/2017 - 06/2015
3	Cardiac Resynchronization Therapy 12/2014 - 02/2010
3	Catheters 01/2014 - 07/2007
2	Orthopedic Procedures 03/2014 - 08/2006
2	Stents 01/2014 - 09/2013
2	Bed Rest (Bedrest) 05/2013 - 09/2010
2	Defibrillators (Defibrillator) 01/2013 - 02/2010
2	Embolectomy 01/2012 - 01/2009
2	Thrombolytic Therapy 01/2012 - 03/2005
2	Central Venous Catheters 01/2011 - 04/2006
2	Perioperative Period 07/2007 - 11/2006
1	Duration of Therapy 04/2023
1	Aftercare (After-Treatment) 01/2018
1	Drug Therapy (Chemotherapy) 08/2017
1	Spinal Anesthesia 05/2017
1	General Anesthesia 05/2017
1	Epidural Anesthesia 05/2017
1	Anesthesia 05/2017